Trauma Monthly

Published by: Kowsar

Effects of Melissa officinalis L. on Reducing Stress, Alleviating Anxiety Disorders, Depression, and Insomnia, and Increasing Total Antioxidants in Burn Patients

Shirin Chehroudi 1 , Mohammad Javad Fatemi 2 , * , Mohsen Saberi Isfeedvajani 3 , Seyed Hamid Salehi 4 , Hossein Akbari 2 and Roghayeh Samimi 5
Authors Information
1 Burn Research Center, Iran University of Medical Sciences, Tehren, IR Iran
2 Department of of Plastic Surgery, Burn Research Center, Iran University of Medical Sciences, Tehren, IR Iran
3 Quran and Hadith Research Center and Department of Community Medicine, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Department of General Surgery, Burn Research Center, Iran University of Medical Sciences, Tehren, IR Iran
5 Department of Nursing, Burn Research Center, Iran University of Medical Sciences, Tehren, IR Iran
Article information
  • Trauma Monthly: July 2016, 22 (4); e33630
  • Published Online: July 24, 2016
  • Article Type: Research Article
  • Received: October 6, 2015
  • Revised: December 28, 2015
  • Accepted: April 4, 2016
  • DOI: 10.5812/traumamon.33630

To Cite: Chehroudi S, Fatemi M J, Saberi Isfeedvajani M, Salehi S H, Akbari H, et al. Effects of Melissa officinalis L. on Reducing Stress, Alleviating Anxiety Disorders, Depression, and Insomnia, and Increasing Total Antioxidants in Burn Patients, Trauma Mon. 2016 ; 22(4):e33630. doi: 10.5812/traumamon.33630.

Copyright © 2016, Trauma Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Hertford C, Cream AE. Thermal Injuries. Synopsis of surgery. 1980;
  • 2. Park BH, Saxer C, Srinivas SM, Nelson JS, de Boer JF. In vivo burn depth determination by high-speed fiber-based polarization sensitive optical coherence tomography. J Biomed Opt. 2001; 6(4): 474-9[DOI][PubMed]
  • 3. Portugal M, Barak V, Ginsburg I, Kohen R. Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations. Biomed Pharmacother. 2007; 61(7): 412-22[DOI][PubMed]
  • 4. Oktay M, Gülçin İ, Küfrevioğlu Ö. Determination of in vitro antioxidant activity of fennel (Foeniculum vulgare) seed extracts. Food Sci Technol. 2003; 36(2): 263-71
  • 5. Gulcin I. Antioxidant activity of L-adrenaline: a structure-activity insight. Chem Biol Interact. 2009; 179(2-3): 71-80[DOI][PubMed]
  • 6. Sen C, Packer L, Hänninen O. Handbook of oxidants and antioxidants in exercise. 2000;
  • 7. Gulcin I, Buyukokuroglu ME, Oktay M, Kufrevioglu OI. Antioxidant and analgesic activities of turpentine of Pinus nigra Arn. subsp. pallsiana (Lamb.) Holmboe. J Ethnopharmacol. 2003; 86(1): 51-8[PubMed]
  • 8. Prakash D, Upadhyay G, Singh BN, Singh HB. Antioxidant and free radical-scavenging activities of seeds and agri-wastes of some varieties of soybean (Glycine max). Food Chem. 2007; 104(2): 783-90[DOI]
  • 9. Gulcin I, Oktay M, Kufrevioglu OI, Aslan A. Determination of antioxidant activity of lichen Cetraria islandica (L) Ach. J Ethnopharmacol. 2002; 79(3): 325-9[PubMed]
  • 10. Gulcin I, Mshvildadze V, Gepdiremen A, Elias R. The antioxidant activity of a triterpenoid glycoside isolated from the berries of Hedera colchica: 3-O-(beta-D-glucopyranosyl)-hederagenin. Phytother Res. 2006; 20(2): 130-4[DOI][PubMed]
  • 11. Gülçin İ, Elias R, Gepdiremen A, Boyer L. Antioxidant activity of lignans from fringe tree (Chionanthus virginicus L.). Eur Food Res Technol. 2006; 223(6): 759-67[DOI]
  • 12. Young E, Liberzon I. Stress and Anxiety Disorders. Hormones, Brain and behavior. 2002; 5[DOI]
  • 13. Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, Muller N, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004; 34(4): 597-611[DOI][PubMed]
  • 14. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2163-96[DOI][PubMed]
  • 15. Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Moller HJ, et al. Social functioning in depression: a review. J Clin Psychiatry. 2000; 61(4): 268-75[PubMed]
  • 16. Hickie I. Is depression overdiagnosed? . BMJ. 2007; 335(7615): 329
  • 17. Bischkopf J, Wittmund B, Angermeyer MC. Alltag mit der Depression des Partners. Psychotherapeut. 2002; 47(1): 11-5[DOI]
  • 18. Ahrari F, Salehi SH, Fatemi MJ, Soltani M, Taghavi S, Samimi R. Severity of symptoms of depression among burned patients one week after injury, using Beck Depression Inventory-II (BDI-II). Burns. 2013; 39(2): 285-90[DOI][PubMed]
  • 19. The ICD-10 classification of mental and behavioral disorders. 1992;
  • 20. Larzelere MM, Wiseman P. Anxiety, depression, and insomnia. Prim Care. 2002; 29(2): 339-60[PubMed]
  • 21. Busto U, Sellers EM. Pharmacologic aspects of benzodiazepine tolerance and dependence. J Subst Abuse Treat. 1991; 8(1-2): 29-33[PubMed]
  • 22. Kavan MG, Elsasser G, Barone EJ. Generalized anxiety disorder: practical assessment and management. Am Fam Physician. 2009; 79(9): 785-91[PubMed]
  • 23. Vorbach EU, Görtelmeyer R, Brüning J. Therapie von insomnien: wirksamkeit und vertraeglichkeit eines baldrianpraeparats. Psychopharmakotherap. 1996; 3: 109-15
  • 24. Bourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol. 1997; 11(2): 127-32[PubMed]
  • 25. Viola H, Wolfman C, Levi de Stein M, Wasowski C, Pena C, Medina JH, et al. Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae). J Ethnopharmacol. 1994; 44(1): 47-53[PubMed]
  • 26. European pharmacopeia . Melissa Officinalis L. Monograph. 2005; 2
  • 27. Fazli D, Malekirad AA, Pilevarian AA, Salehi H. Effects of Melissa officinalis L. on oxidative status and biochemical parameters in occupationally exposed workers to aluminum: A before after clinical trial. Int J Pharmacology. 2012; 8(5): 445-8
  • 28. de Sousa AC, Alviano DS, Blank AF, Alves PB, Alviano CS, Gattass CR. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J Pharm Pharmacol. 2004; 56(5): 677-81[DOI][PubMed]
  • 29. Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002; 72(4): 953-64[PubMed]
  • 30. Kennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003; 28(10): 1871-81[DOI][PubMed]
  • 31. Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. 2004; 66(4): 607-13[DOI][PubMed]
  • 32. Kennedy DO, Little W, Haskell CF, Scholey AB. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 2006; 20(2): 96-102[DOI][PubMed]
  • 33. Lamaison JL, Petitjean-Freytet C, Carnat A. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid [in French]. Pharm Acta Helv. 1991; 66(7): 185-8[PubMed]
  • 34. Campos AM, Lissi EA. Evaluation of the antioxidant capacity of herbal teas by a procedure based on the bleaching of ABTS radical cations. Bol Soc Chil Quim. 1995; 40(4): 375-81
  • 35. Bisset NG. Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis. 1994; : 329-32
  • 36. Dimitrova Z, Dimov B, Manolova N, Pancheva S, Ilieva D, Shishkov S. Antiherpes effect of Melissa officinalis L. extracts. Acta Microbiol Bulg. 1993; 29: 65-72[PubMed]
  • 37. Yamasaki K, Nakano M, Kawahata T, Mori H, Otake T, Ueba N, et al. Anti-HIV-1 activity of herbs in Labiatae. Biol Pharm Bull. 1998; 21(8): 829-33[PubMed]
  • 38. Wagner H, Sprinkmeyer L. Pharmacological effect of balm spirit. Deut Apoth Ztg. 1973; 113: 1159-66
  • 39. Zeraatpishe A, Oryan S, Bagheri MH, Pilevarian AA, Malekirad AA, Baeeri M, et al. Effects of Melissa officinalis L. on oxidative status and DNA damage in subjects exposed to long-term low-dose ionizing radiation. Toxicol Ind Health. 2011; 27(3): 205-12[DOI][PubMed]
  • 40. Kucera LS, Cohen RA, Herrmann EC. Antiviral activities of extracts of the lemon balm plant. Ann N Y Acad Sci. 1965; 130(1): 474-82[PubMed]
  • 41. Lopez V, Martin S, Gomez-Serranillos MP, Carretero ME, Jager AK, Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res. 2009; 34(11): 1955-61[DOI][PubMed]
  • 42. Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab. 2011; 4(3): 211-8[DOI][PubMed]
  • 43. Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine. 2010; 17(6): 397-403[DOI][PubMed]
  • 44. Alvi T, Assad F, Malik MA. Anxiety and depression in burn patients. J Ayub Med Coll Abbottabad. 2009; 21(1): 137-41[PubMed]
  • 45. Robert R, Blakeney PE, Villarreal C, Rosenberg L, Meyer WJ. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry. 1999; 38(7): 873-82[DOI][PubMed]
  • 46. Boeve SA, Aaron LA, Martin-Herz SP, Peterson A, Cain V, Heimbach DM, et al. Sleep disturbance after burn injury. J Burn Care Rehabil. 2002; 23(1): 32-8[PubMed]
  • 47. Jaffe SE, Patterson DR. Treating sleep problems in patients with burn injuries: practical considerations. J Burn Care Rehabil. 2004; 25(3): 294-305[PubMed]
  • 48. Armour A, Gottschlich MM, Khoury J, Warden GD, Kagan RJ. A randomized, controlled prospective trial of zolpidem and haloperidol for use as sleeping agents in pediatric burn patients. J Burn Care Res. 2008; 29(1): 238-47[DOI][PubMed]
  • 49. Horton JW, White DJ. Role of xanthine oxidase and leukocytes in postburn cardiac dysfunction. J Am Coll Surg. 1995; 181(2): 129-37[PubMed]
  • 50. Cetinkale O, Senel O, Bulan R. The effect of antioxidant therapy on cell-mediated immunity following burn injury in an animal model. Burns. 1999; 25(2): 113-8[PubMed]
  • 51. Frisman E, Racz O, Chmelarova A. Red cell antioxidant enzymes and prognostic indexes in patients with burns. Burns. 2013; 39(3): 458-64[DOI][PubMed]
  • 52. Rasik AM, Shukla A. Antioxidant status in delayed healing type of wounds. Int J Exp Pathol. 2000; 81(4): 257-63[PubMed]
  • 53. Traber MG, Leonard SW, Traber DL, Traber LD, Gallagher J, Bobe G, et al. alpha-Tocopherol adipose tissue stores are depleted after burn injury in pediatric patients. Am J Clin Nutr. 2010; 92(6): 1378-84[DOI][PubMed]
  • 54. Traber MG, Shimoda K, Murakami K, Leonard SW, Enkhbaatar P, Traber LD, et al. Burn and smoke inhalation injury in sheep depletes vitamin E: kinetic studies using deuterated tocopherols. Free Radic Biol Med. 2007; 42(9): 1421-9[DOI][PubMed]
  • 55. Al-Jawad FH, Sahib AS, Al-Kaisy AA. Role of antioxidants in the treatment of burn lesions. Ann Burns Fire Disasters. 2008; 21(4): 186-91[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments